Alan Chu
- Pharmacology top 10%
-
- Epigenetics and DNA Methylation 3
- Circular RNAs in diseases 3
- DNA Repair Mechanisms 2
- Protein Kinase Regulation and GTPase Signaling 2
- RNA modifications and cancer 2
-
- MicroRNA in disease regulation 3
-
- Ferroptosis and cancer prognosis 2
-
- Esophageal Cancer Research and Treatment 2
- Co-authors
- Jeremy S. CaldwellBin WangHong YinDeborah G. NguyenWěi LiFrancella J. OteroDavid von SchackV.A.M. Vincent
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (2 papers)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Alan Chu
15 papers receiving 486 citations
Peers
Comparison fields: 5 of 77
- Cellular and Molecular Neuroscience 131
- Pharmacology 121
- Neurology 56
- Molecular Biology 300
- Physiology 14
Countries citing papers authored by Alan Chu
This map shows the geographic impact of Alan Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Chu more than expected).
Fields of papers citing papers by Alan Chu
This network shows the impact of papers produced by Alan Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Chu. The network helps show where Alan Chu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alan Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 17 | |
| 10 | 2022 | 7 | |
| 11 | 2021 | 25 | |
| 12 | 2020 | 0 | |
| 13 | 2017 | 8 | |
| 14 | 2017 | 2 | |
| 15 | 2009 | 25 | |
| 16 | 2009 | 256 | |
| 17 | 2004 | 115 | |
| 18 | 1979 | 19 |
About Alan Chu
Alan Chu is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 18 papers that have together received 496 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (3 papers), MicroRNA in disease regulation (3 papers), Circular RNAs in diseases (3 papers), DNA Repair Mechanisms (2 papers), Ferroptosis and cancer prognosis (2 papers), Esophageal Cancer Research and Treatment (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (131 citations), Pharmacology (121 citations) and Neurology (56 citations). Alan Chu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Jeremy S. Caldwell, Bin Wang, Hong Yin, Deborah G. Nguyen, Wěi Li, Francella J. Otero, David von Schack, V.A.M. Vincent, Li Gan and Shiming Ye. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.